TY - JOUR
T1 - Prognostic Impact of Immune-Related Adverse Events in Patients with Non–Small Cell Lung Cancer Treated with Second-Line Nivolumab: A Single-Center Real-World Experience
Y1 - 2026
PY - 2026
DA - 2026
N1 - doi:263046
T2 - EURASIAN JOURNAL OF MEDICIAL INVESTIGATION
JF - EURASIAN JOURNAL OF MEDICIAL INVESTIGATION
JO - EJMI
SP - 46
EP - 53
VL - 10
IS - 1
SN - 
M3 - doi:263046
UR - https://dx.doi.org/10.14744/ejmi.263046
Y2 - 2026
ER -